Description

Uracil, 6-Amino-5-[2-(Benzylmethylamino)Acetamido]-1,3-Dimethyl- (6Ci) is a specialized uracil derivative with a complex substituted acetamido side chain. This compound is of significant interest in advanced pharmaceutical research and development, particularly as a key intermediate or building block for novel therapeutic agents. Its unique structure makes it valuable for medicinal chemists and R&D laboratories focused on nucleoside analogs, enzyme inhibitors, and targeted drug discovery programs. The CAS number for this compound is 101269-40-3.

Application

This high-purity chemical intermediate serves critical functions in several advanced research and industrial sectors:

• Pharmaceutical Intermediate: A key building block in the synthesis of novel nucleoside-based drugs, including potential antiviral and anticancer agents.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to develop new enzyme inhibitors and receptor modulators.
• Biochemical Tool Compound: Employed in biochemical assays to study enzyme mechanisms, particularly those involving uracil metabolism or processing.
• Organic Synthesis: Serves as a versatile intermediate for constructing more complex heterocyclic systems and functionalized nucleosides.
• Academic & Institutional R&D: Utilized in university and government research laboratories for fundamental studies in chemical biology and drug design.

Basic Information

Product Name	Uracil, 6-Amino-5-[2-(Benzylmethylamino)Acetamido]-1,3-Dimethyl- (6Ci)
CAS No.	101269-40-3
Molecular Formula	C₁₆H₂₁N₅O₃
Molecular Weight	331.38 g/mol
Synonyms	1,3-Dimethyl-6-amino-5-[(2-(benzylmethylamino)acetamido)]uracil; 6-Amino-5-[2-(benzylmethylamino)acetamido]-1,3-dimethyluracil; 5-Acetamido-6-amino-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione derivative; N-[2-(Benzylmethylamino)acetyl]-6-amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide; (6Ci) Uracil derivative; Research Compound 101269-40-3
EINECS	Contact for details

Quality Control

Our Uracil derivative is produced under controlled conditions to ensure high purity and batch-to-batch consistency, meeting the stringent requirements of research and pharmaceutical development. All batches undergo comprehensive analytical characterization, including HPLC for purity assessment and spectroscopic methods (NMR, MS) for structural confirmation. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with each shipment to support your quality and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.